Chronic mesenteric ischemia-induced intestinal dysbiosis resolved after revascularization

Jennifer A Munley1, Ravinder Nagpal2, Nancy C Hanson1

  • 1Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, University of Florida College of Medicine, Gainesville, FL.

Abstract

Insights

Chronic mesenteric ischemia (CMI) patients exhibit intestinal dysbiosis, characterized by reduced microbial diversity. Revascularization therapy restores gut microbiome balance, highlighting the importance of intestinal perfusion for gut health.

Area of Science:

  • Gastroenterology and Hepatology
  • Microbiology
  • Vascular Surgery

Background:

  • Chronic mesenteric ischemia (CMI) results from intestinal malperfusion, with revascularization carrying significant risks.
  • Ischemia-reperfusion injury is a potential cause of perioperative morbidity in CMI patients.
  • The intestinal microbiome plays a crucial role in regulating metabolism and immune responses.

Purpose of the Study:

  • To investigate microbiome perturbations in CMI patients.
  • To determine if these perturbations contribute to inflammation.
  • To assess if the microbiome normalizes post-revascularization.

Main Methods:

  • Prospective study of CMI patients undergoing mesenteric revascularization (2019-2020).
  • Stool samples collected preoperatively, perioperatively, and postoperatively, compared to healthy controls.
  • 16S rRNA sequencing and QIIME2 bioinformatics analysis for microbiome assessment.

Main Results:

  • CMI patients showed significantly reduced bacterial alpha-diversity preoperatively compared to controls.
  • Revascularization partially restored microbial richness and evenness.
  • Increased abundance of Bacteroidetes and Clostridia preoperatively decreased postoperatively.

Conclusions:

  • CMI patients exhibit intestinal dysbiosis (loss of alpha-diversity) that resolves after revascularization.
  • Restoration of the microbiome post-revascularization underscores the importance of intestinal perfusion.
  • Microbiome modulation may offer potential interventions for postoperative outcomes.